Auswahl der wissenschaftlichen Literatur zum Thema „Récepteurs de la thrombine“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Récepteurs de la thrombine" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Récepteurs de la thrombine"
Jandrot-Perrus, Martine. „La thrombine et ses récepteurs : implications dans l’hémostase et le développement embryonnaire“. médecine/sciences 18, Nr. 1 (Januar 2002): 19–22. http://dx.doi.org/10.1051/medsci/200218119.
Der volle Inhalt der QuelleVanObberghen-Schilling, E., und J. Pouysségur. „Le récepteur de la thrombine et ses implications dans la prolifération des cellules vasculaires“. médecine/sciences 9, Nr. 10 (1993): 1043. http://dx.doi.org/10.4267/10608/2807.
Der volle Inhalt der QuelleRullier, A., J. Gillibert-Duplantier, G. Cubel, M. Capdepont, N. Senant, C. Petibois, P. Costet und J. Rosenbaum. „CO 13-L’invalidation du gène du protease-activated receptor 1, le principal récepteur de la thrombine, protège de la fibrose hépatique“. Gastroentérologie Clinique et Biologique 30, Nr. 8-9 (August 2006): 1040. http://dx.doi.org/10.1016/s0399-8320(06)73392-9.
Der volle Inhalt der QuelleBoutière-Albanèse, Brigitte. „Temps de thrombine“. EMC - Biologie Médicale 1, Nr. 1 (Januar 2006): 1–4. http://dx.doi.org/10.1016/s2211-9698(06)76183-0.
Der volle Inhalt der QuelleA., F. „Inhibiteur de la thrombine“. Médecine des Maladies Métaboliques 3, Nr. 6 (Dezember 2009): 614. http://dx.doi.org/10.1016/s1957-2557(09)73631-4.
Der volle Inhalt der QuelleHorellou, Marie-Hélè;ne, Jacqueline Conard und Michel Samama. „Allongement du temps de thrombine“. EMC - Traité de médecine AKOS 1, Nr. 1 (Januar 2006): 1–2. http://dx.doi.org/10.1016/s1634-6939(06)75179-1.
Der volle Inhalt der QuelleManus, Jean-Marie. „D’une anti-thrombine à l’autre“. Revue Francophone des Laboratoires 2009, Nr. 412 (Mai 2009): 13. http://dx.doi.org/10.1016/s1773-035x(09)73913-9.
Der volle Inhalt der QuellePrati, Clément, Evelyne Racadot, Jean-Pierre Cédoz, Éric Toussirot und Daniel Wendling. „Polyarthrite rhumatoïde et génération de thrombine“. Revue du Rhumatisme 79, Nr. 6 (Dezember 2012): 575–76. http://dx.doi.org/10.1016/j.rhum.2012.03.011.
Der volle Inhalt der QuelleLetonturier, Philippe. „Un inhibiteur de thrombine appelé ximélagatran“. La Presse Médicale 34, Nr. 5 (März 2005): 402. http://dx.doi.org/10.1016/s0755-4982(05)83930-2.
Der volle Inhalt der QuelleEspitia, O., und M. Fouassier. „Le test de génération de thrombine“. La Revue de Médecine Interne 36, Nr. 10 (Oktober 2015): 690–93. http://dx.doi.org/10.1016/j.revmed.2015.04.013.
Der volle Inhalt der QuelleDissertationen zum Thema "Récepteurs de la thrombine"
Faraut, Brice. „Synaptogénèse et plasticité neuromusculaire : conséquences de l'activation du récepteur de la thrombine, PAR-1“. Paris 5, 2004. http://www.theses.fr/2004PA05P612.
Der volle Inhalt der QuelleThrombin is a serine protease that regulates numerous cellular functions by activating via specific proteolytic cleavage a family of G-protein-coupled receptors (PARs). The thrombin receptor PAR-1 and the thrombin inhibitor protease nexin-1 are both expressed by muscle cells during the formation of the neuromuscular junction (NMJ). We have then hypothesized that thrombin was involved in the formation and plasticity of the NMJ. We show in myotubes in vitro that thrombin, by activating PAR-1, decreases the expression of the acetylcholine receptor (AChR) while its specific inhibitor, hirudin, increases its expression. In addition, this effect of thrombin is mediated through intracellular calcium signals IP3 receptor-dependent. Then, in neuron-myotube cocultures, we show that thrombin via PAR-1 decreases neuromuscular contact size whereas hirudin has the opposite effect. Therefore, we have studied the expression of the muscle-specific tyrosine-kinase receptor, MuSK, which activation leads to the aggregation of AChRs mediated by rapsyn and of other post-synaptic proteins during the formation of neuromuscular contacts. We find that rapsyn expression is not changed but the one of MuSK is reduced in presence of thrombin. In conclusion, this study reveals a signaling pathway for AChR regulation by thrombin and significant modifications of neuromuscular synaptogenesis when MuSK and AChR levels are reduced by thrombin. Recently, mutations in MuSK gene have been identified by our team for the first time in neuromuscular human pathology. To study the pathogen features of these mutations, this latter have been expressed in muscle cells and the repercussion on neuromuscular synaptogenesis were analysed in vitro. We find that a nonsense mutation of the intracellular domain of MuSK decreases AChR e-subunit gene transcription and also induces an exuberant axonal growth in neuron-myotube cocultures. All together, this data contribute to a better comprehension of the mechanisms involved in the formation and the maintenance of the NMJ
Zolotoff, Cindy. „Effets combinés de l'hypoxie intermittente et de la thrombine sur un modèle in vitro de Barrière Hémato-Encéphalique“. Electronic Thesis or Diss., Lyon, 2021. http://www.theses.fr/2021LYSES020.
Der volle Inhalt der QuelleObstructive sleep apnea (OSA) is characterized by decreases or cessation of airflow followed by periods of reoxygenation. Several studies suggest a link with the onset of neurodegenerative diseases that could be due to an alteration of the blood-brain barrier (BBB), an interface that protects the brain from potential harmful compounds. This interface is made up of endothelial cells connected by junctional proteins that limit passage, and they also possess efflux pumps that play a role in detoxifying molecules. Repeated episodes of intermittent hypoxia (IH) would be at the origin of the alteration of this BBB. Other factors could be involved since OSA also increases the incidence of vascular pathologies and thrombin, a coagulation protease acting through its PAR receptors, could be increased. We therefore developed a cellular model of IH which allowed us to see that IH induced: a disruption of the BBB marked by a decrease in the expression of junction proteins, an increase in permeability and a deregulation of efflux pumps. Next, we combined IH and thrombin at two concentrations. IH alone or combined with a high dose of thrombin increases BBB permeability and PAR-1 expression, an effect that can be reversed by the use of dabigatran. IH combined with a lower dose of thrombin limits BBB permeability and increases PAR-3 expression. Thus, this work has allowed a first approach of the cellular mechanisms taking place in OSA
Saci, Abdelhafid. „Etude de la signalisation plaquettaire : implication de p120Cbl, phosphatidylinositol 3-kinase (PI 3-K) et Grb2“. Paris 5, 2001. http://www.theses.fr/2001PA05P605.
Der volle Inhalt der QuelleBlood platelets are anucleated and terminaly differenciated cells. A number of receptors are present on platelet membrane and mediate signalling and activation in response to various agonists. The action of an agonist triggers an inside-out signalling which activates αIIb-β3 integrin. The latter becomes able to link fibrinogen and transduces a secondary outside-in signalling. We first studied the involvement of the adoptor protein, Cbl, and of the lipid kinase, PI 3-K, in platelet signalling mediated by (i) the receptor for Fc domain of IgG (FcγRIIa), (ii) by the αIIb-β3 integrin (outside-in) and (iii) by the thrombin receptor. .
Jumeau, Céline. „La thrombine et son récepteur PAR-1 comme cibles thérapeutiques dans la prévention et le traitement de la dilatation atriale“. Thesis, Paris 6, 2015. http://www.theses.fr/2015PA066242.
Der volle Inhalt der QuelleAtrial fibrillation (AF) is the most common cardiac arrhythmia. It is characterized by a disorganized and ineffective contraction of the atria and structural changes of the myocardium. Endothelial dysfunction, maintained by inflammation, activate the coagulation cascade and thrombin generation, promoting intra-atrial thrombus formation. Prevention of thromboembolism is a major issue in the management of AF and is done by long-term prescription of oral anticoagulants among which a direct thrombin inhibitor, dabigatran. Our hypothesis is that excess thrombin maintains structural changes in the myocardium via the PAR-1 receptor (protease activated receptor-1) of circulating and myocardial cells. The objective is to identify the signaling pathway of thrombin involved in the atrial remodeling. In an atrial dilatation model associated with arrhythmogenic substrate and hypercoagulability, administration of direct thrombin inhibitors or antagonists of PAR-1 oral reduce expansion and arrhythmic susceptibility of the left atrium. These treatments inhibit the induction of myocyte hypertrophic response markers, β-MHC and BNP and remodeling of the extracellular matrix markers, CTGF and PAI-1. With explant of left atria culture, we show that these phenotypic changes are induced by the Rho pathway / ROCK and STAT3 transcription factor. Our results also indicate that the expression and activity of ErbBs receptors known to be transactivated via PAR-1, are modified during development of atrial dilatation. Thrombin participates in these changes only when the atrial remodeling is established. These results show that thrombin participates in atrial remodeling associated with an arrhythmogenic substrate, and direct thrombin inhibitors and PAR-1 antagonists are potential therapeutic agents to prevent the development of atrial dilation
Li, Ruo Ya. „Clonage d'une tyrosine-phosphatase membranaire (HPTP-béta) et étude de l'implication de la SH-PTP1 dans l'agrégation plaquettaire induite par la thrombine“. Toulouse 3, 1995. http://www.theses.fr/1995TOU30150.
Der volle Inhalt der QuelleGaits-Iacovoni, Frédérique. „Intervention de protéine tyrosine phosphatases dans l'inhibition de contact des cellules endothéliales et dans l'activation de cellules mégacaryoblastiques“. Toulouse 3, 1995. http://www.theses.fr/1995TOU30245.
Der volle Inhalt der QuelleGuinebault, Christine. „Activation plaquettaire par l'alpha-thrombine : modes de régulation de la phosphatidylinositol 3-kinase et de la phospholipase C-gamma, en relation avec l'organisation du cytosquelette“. Toulouse 3, 1994. http://www.theses.fr/1994TOU30261.
Der volle Inhalt der QuelleMokrane, Ahmed. „Modélisation de la réactivité enzymatique par le formalisme LSCF et étude des effets électrostatiques à longue distance : application à l'activation du récepteur de la thrombine“. Nancy 1, 1997. http://docnum.univ-lorraine.fr/public/SCD_T_1997_0272_MOKRANE.pdf.
Der volle Inhalt der QuelleDufourcq, Pascale. „La thrombomoduline, un marqueur de la lésion endothéliale : approche clinique et expérimentale dans la maladie athéromateuse“. Bordeaux 2, 1994. http://www.theses.fr/1994BOR2P019.
Der volle Inhalt der QuelleSmadja, David. „Rôle du récepteur de la thrombine PAR-1 dans l'expansion des progéniteurs endothéliaux“. Paris 5, 2006. http://www.theses.fr/2006PA05P625.
Der volle Inhalt der QuelleThe injection of endothelial progenitor cells (EPCs) in preclinical models of ischemia has been shown to enhance neovascularization. However, the scarcity of EPCs in human peripheral blood is a limitation for of its use as a cell therapy product, and the development of an expansion procedure is a crucial issue. In this work, we have characterized EPCs during in vitro expansion, using EPCs derived from cord blood CD34+ cells. An increased expression of KDR/VEGFR2 along expansion was observed, together with an increase of in vitro angiogenic properties. We also show the presence of the thrombin receptor PAR-1 on expanded EPCs. The importance of PAR-1 in blood vessel development has been demonstrated in knockout mice. As EPCs are thought to be involved in postnatal vasculogenesis, we examined the effect of PAR-1 activation on EPCs. PAR-1 activation induced EPCs proliferation, resulting of an angiopoietin 2 upregulation. PAR-1 activation also enhanced actin reorganization, promoting both spontaneous migration in a Boyden chamber assay and migration toward SDF-1. Finally, PAR-1 stimulation by SFLLRN increased the formation of capillary-like structures formed by EPCs in Matrigel, and this effect was abrogated by anti-CXCR-4 and anti-SDF-1 antibodies. All together, PAR-1 activation on cord blood derived EPCs led to a proangiogenic effect. In vivo, enhancement of angiogenic properties of EPCs by thrombin generated at the target site might promote vasculogenesis and thrombus resorption. Our data suggest that SFLLRN peptide could be used to expand cord blood derived-EPCs ex vivo. However, this effect was not found on EPCs isolated from adult blood, underlining the usefulness of a procedure designed to mobilize immature endothelial cells from bone marrow to peripheral blood
Bücher zum Thema "Récepteurs de la thrombine"
Advances in adrenergic receptor biology. Amsterdam: Elsevier, 2011.
Den vollen Inhalt der Quelle finden(Firm), Knovel, Hrsg. Microwave receivers with electronic warfare applications. 2. Aufl. Raleigh, N.C: Scitech Pub., 2005.
Den vollen Inhalt der Quelle findenEisenson, Henry L. Scanners & secret frequencies. San Diego: Index Pub. Group, 1993.
Den vollen Inhalt der Quelle findenR, Ruffolo Robert, und Hollinger Mannfred A, Hrsg. G-protein coupled transmembrane signaling mechanisms. Boca Raton, Fla: CRC Press, 1995.
Den vollen Inhalt der Quelle findenM, Gotto Antonio, O'Malley Bert W und Fondation Princesse Liliane, Hrsg. The role of receptors in biology and medicine: Proceedings of the Ninth Argenteuil Symposium. New York: Raven Press, 1986.
Den vollen Inhalt der Quelle findenSpampinato, Santi M. Opioid receptors: Methods and protocols. New York: Humana Press, 2015.
Den vollen Inhalt der Quelle findenE, Giesen-Crouse, Hrsg. Peripheral benzodiazepine receptors. London: Academic Press, 1993.
Den vollen Inhalt der Quelle finden1936-, Kalsner Stanley, Westfall Thomas C und New York Academy of Sciences., Hrsg. Presynaptic receptors and the question of autoregulation of neurotransmitter release. New York, N.Y: New York Academy of Sciences, 1990.
Den vollen Inhalt der Quelle findenJacques, Bertoglio, Fradelizi Didier und Institut national de la santé et de la recherche médicale (France), Hrsg. Lymphokine receptor interactions =: Interactions lymphokines-récepteurs : proceedings of the VIth International Lymphokine Workshop held in Evian (France), October 23-27, 1988. Paris: INSERM, 1989.
Den vollen Inhalt der Quelle findenLipsky, Stephen E. Microwave passive direction finding. New York: Wiley, 1987.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Récepteurs de la thrombine"
Robert, Jacques. „Les voies des récepteurs lymphocytaires“. In Signalisation cellulaire et cancer, 155–62. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-8178-0028-8_14.
Der volle Inhalt der QuelleRobert, Jacques. „Les voies des récepteurs nucléaires“. In Signalisation cellulaire et cancer, 163–75. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-8178-0028-8_15.
Der volle Inhalt der QuelleRobert, Jacques. „Récepteurs couplés à des canaux ioniques“. In Signalisation cellulaire et cancer, 177–87. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-8178-0028-8_16.
Der volle Inhalt der QuelleLoriot, Y., und B. Besse. „Molécules inhibitrices des récepteurs du VEGF“. In Les thérapies ciblées, 65–78. Paris: Springer Paris, 2008. http://dx.doi.org/10.1007/978-2-287-36008-4_5.
Der volle Inhalt der QuelleRobert, Jacques. „Les voies des récepteurs couplés aux protéines G“. In Signalisation cellulaire et cancer, 91–102. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-8178-0028-8_7.
Der volle Inhalt der QuelleRobert, Jacques. „Les récepteurs toll-like, l’interleukine 1 et le NFκB“. In Signalisation cellulaire et cancer, 145–54. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-8178-0028-8_13.
Der volle Inhalt der QuelleRobert, Jacques. „Les facteurs de croissance et les récepteurs à activité tyrosine kinase“. In Signalisation cellulaire et cancer, 21–43. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-8178-0028-8_2.
Der volle Inhalt der QuelleBedel, R., C. Borg und P. Saas. „CTLA-4 et Toll-like récepteurs: de nouvelles cibles en immunothérapie“. In Les thérapies ciblées, 169–95. Paris: Springer Paris, 2008. http://dx.doi.org/10.1007/978-2-287-36008-4_12.
Der volle Inhalt der QuelleHammar, K., S. Moulessehoul, A. Tou, F. Kemas, H. Benamar und M. Ghalek. „Ciblage des récepteurs ErbB (HER) chez 45 patientes atteintes de cancer du sein“. In Cancer du sein : surdiagnostic, surtraitement, 247. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0249-7_54.
Der volle Inhalt der QuelleFayette, J., B. Fleury und J. Y. Blay. „Nouvelles approches dans les thérapeutiques ciblées: les récepteurs des facteurs de croissance de type insuline (IGF) et les cyclines“. In Les thérapies ciblées, 157–68. Paris: Springer Paris, 2008. http://dx.doi.org/10.1007/978-2-287-36008-4_11.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Récepteurs de la thrombine"
Lim, Chae Young, Eunpyo Choi, Youngkyu Park und Jungyul Park. „3D photonic crystal-based biosensor functionalized with quantum dot-based aptamer for thrombine detection“. In SPIE Photonics Europe, herausgegeben von Sergei G. Romanov, Gabriel Lozano, Dario Gerace, Christelle Monat und Hernán R. Míguez. SPIE, 2014. http://dx.doi.org/10.1117/12.2054149.
Der volle Inhalt der QuelleVerbeet, M. Ph, R. F. Evers, A. Leyte, H. L. Lamain, A. J. J. Van Ooyen, J. A. Van Mourik und H. Pannekoek. „DETERMINATION OF THE DOMAINS OF FACTOR VIII ESSENTIAL FOR PROCOAGULANT ACTIVITY“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643613.
Der volle Inhalt der QuelleGellee, T., und B. Philippe. „Utilisation combinée des biomatériaux xénogéniques et d’os autologue en chirurgie reconstructrice préimplantaire : Réflexions à propos de quatre indications méconnues“. In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206602008.
Der volle Inhalt der Quelle